Navigation Links
Fewer women need repeat breast cancer surgeries with new service at University of Michigan
Date:2/28/2012

ANN ARBOR, Mich. Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist.

A new service at the University of Michigan Comprehensive Cancer Center cuts that number drastically by having pathologists on-site in the operating suite to assess tumors and lymph nodes immediately after they are removed. Meanwhile, the surgeon and patient remain in the operating room until the results are back, and any additional operating can be done immediately.

This cut the number of second surgeries needed by 64 percent, to one of every 10 women.

U-M began offering the service about two years ago at its East Ann Arbor Ambulatory Surgery Center, where the majority of outpatient breast cancer surgeries now occur. A study evaluating 271 patients treated eight months before and 278 treated eight months after this program began appears in the American Journal of Surgery.

"The frequent need for second surgeries among patients undergoing breast cancer surgery represents a tremendous burden for patients. Beyond the inconvenience and additional time away from work, additional surgeries can result in worse cosmetic outcomes and increased complication rates. Our experience shows that offering on-site pathology consultation has a substantial impact on quality of care," says lead study author Michael S. Sabel, M.D., associate professor of surgery at the U-M Medical School.

Patients must return to the operating room for two primary reasons: to remove additional tissue when the cancer cells are too close to the margin of tissue removed; and in some cases, to remove additional lymph nodes if the initial sentinel lymph node biopsy tests positive for cancer.

Before the on-site pathology, 25 percent of patients needed a second operation to remove more tissue, compared to 11 percent after the service began. Among patients wi
'/>"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Recession May Mean Fewer Nips & Tucks
2. Fewer platelets could be used for some cancer and bone-marrow transplantation patients
3. Fewer Deaths in Larger, Busier Hospitals
4. Pitt/Magee research finds women with preeclampsia have fewer blood vessel precursor cells
5. Better patient safety linked to fewer medical malpractice claims in California
6. Safer Patients Mean Fewer Malpractice Suits
7. Study finds post-transplant patients off steroids have fewer cardiovascular events
8. Prevention Gets Credit for Fewer Heart Deaths
9. Fewer Sugary Drinks, Less High Blood Pressure
10. Fewer Boys Born Following 9/11 Attacks
11. Simple change results in fewer unnecessary imaging exams for patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fewer women need repeat breast cancer surgeries with new service at University of Michigan
(Date:7/23/2014)... 2014 Four hospitals affiliated with the ... the latest ranking of the country’s best hospitals by ... online today and slated for publication in August, the ... Hospital (AGH), Forbes Hospital, Saint Vincent Hospital and West ... clinical specialties. , “There is no higher ...
(Date:7/23/2014)... Kathleen Doheny HealthDay Reporter ... surgery appears to have an additional side benefit -- ... to a new study. The study found that ... reported having incontinence prior to the procedure. After surgery, ... improved or disappeared, said study researcher Dr. Leslee Subak, ...
(Date:7/23/2014)... -- For patients infected with both HIV and hepatitis ... viruses, a small study suggests. Researchers said doctors ... people with the two diseases. "The findings ... important role in the management of individuals with [hepatitis ... Sherman, a professor of medicine at the University of ...
(Date:7/23/2014)... a massive effort to catalog the molecular causes ... Cancer Institute, have identified four subtypes of tumors ... They say the new classification promises to advance ... third-leading cancer killer worldwide. , In a report ... Genome Atlas Research Network said they analyzed 295 ...
(Date:7/23/2014)... cancer genes have been focused on the regions of ... in the form of amino acids thus proteins. But ... or activator which controls the expression and activity of ... of the role exerted such DNA fragment in tumor ... Nature in collaboration with the group of Manel ...
Breaking Medicine News(10 mins):Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 2Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3
... ... ... ... ...
... ... ... ... ...
... ... Weight-Control Formulas: Licorice Flavonoid Oil. Licorice Flavonoid Oil is a “nutrigenomic” supplement, meaning it ... ... -- Nutrigenomics is the study of how foods affect genetics and how individual genetic ...
... kept cancer from spreading in mice, researchers say , FRIDAY, ... the spread of the cancer in mice, a new study ... mice with breast cancer. Both involve applying a cold probe ... 30 seconds) of the tumor, while the other takes a ...
... ... ... , ... , , ...
... ... ... ... ...
Cached Medicine News:Health News:Donations Sought for Chilean Relief, Children's Clinics 2Health News:Donations Sought for Chilean Relief, Children's Clinics 3Health News:Donations Sought for Chilean Relief, Children's Clinics 4Health News:Donations Sought for Chilean Relief, Children's Clinics 5Health News:Donations Sought for Chilean Relief, Children's Clinics 6Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 2Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 3Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 4Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 5Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 6Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 7Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 8Health News:Licorice Flavonoid Oil with Glavonoid™ Added to the Swanson Health Products' Swanson Best Weight-Control Formulas 2Health News:Freezing Technique May Stop Breast Cancer 2Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 2Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 3Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 4Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 2Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 3Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 4Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 5
(Date:7/23/2014)... -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical ... in opioid antagonists, announced today that it has ... respect to its naloxone-based opioid overdose reversal nasal ... received an additional commitment from the National Institute ... Institutes of Health ("NIH"), to fund a second ...
(Date:7/23/2014)... , July 23, 2014  Silk Road ... the transcarotid treatment of intra- and extra-cranial cerebrovascular ... P. Wallace to the position of Chief ... lead the company,s Research and Development efforts across ... Prior to joining Silk Road ...
(Date:7/23/2014)... 23, 2014  ACON Equity Partners III, L.P., a ... ("ACON") announced it has completed the purchase of Injured ... Group and Parthenon Capital Partners. IWP is a leading ... Compensation, Automobile Personal Injury Protection and Personal Injury pharmacy ... As part of this transaction, ACON ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3ACON Investments Acquires Injured Workers Pharmacy 2ACON Investments Acquires Injured Workers Pharmacy 3
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced ... offer and sell shares of its common stock and warrants ...  The Company also intends to grant the underwriters a 45-day ... shares and warrants sold in the public offering to cover ...
... Food and Drug Administration has licensed HEMACORD™ (Hematopoietic ... cell transplantation, the first such approval of a ... According to the Food and Drug Administration,s ... is "indicated for use in unrelated donor hematopoietic ...
Cached Medicine Technology:ADVENTRX Announces Public Offering of Stock 2ADVENTRX Announces Public Offering of Stock 3FDA Approves New York Blood Center's HEMACORD™ for Stem Cell Transplantation 2FDA Approves New York Blood Center's HEMACORD™ for Stem Cell Transplantation 3
... "mobile operating table" literally! The Alphastar 1132 with ... a general purpose operating table - is as ... a cable connected hand control, an IR-hand control ... is a control panel at the top of ...
... introduce the Cmax operating table that combines ... surgical table with the radiolucence and precise ... the most advanced, versatile surgical table on ... to support advancements in surgical procedures and ...
... The state-of-the-art Opus II urology imaging table ... enhanced patient access, exceptional imaging and advanced ... has the smallest footprint in the industry ... anesthesiologist and can be changed to either ...
Inquire...
Medicine Products: